BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22190001)

  • 1. Testosterone therapy decreases subcutaneous fat and adiponectin in aging men.
    Frederiksen L; Højlund K; Hougaard DM; Mosbech TH; Larsen R; Flyvbjerg A; Frystyk J; Brixen K; Andersen M
    Eur J Endocrinol; 2012 Mar; 166(3):469-76. PubMed ID: 22190001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR spectroscopy of hepatic fat and adiponectin and leptin levels during testosterone therapy in type 2 diabetes: a randomized, double-blinded, placebo-controlled trial.
    Magnussen LV; Andersen PE; Diaz A; Ostojic J; Højlund K; Hougaard DM; Christensen AN; Nielsen TL; Andersen M
    Eur J Endocrinol; 2017 Aug; 177(2):157-168. PubMed ID: 28522646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men.
    Frederiksen L; Nielsen TL; Wraae K; Hagen C; Frystyk J; Flyvbjerg A; Brixen K; Andersen M
    J Clin Endocrinol Metab; 2009 Oct; 94(10):4010-5. PubMed ID: 19755479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
    Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
    J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat.
    Frederiksen L; Glintborg D; Højlund K; Hougaard DM; Brixen K; Rasmussen LM; Andersen M
    Horm Metab Res; 2013 Apr; 45(4):308-13. PubMed ID: 22918704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
    Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
    Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
    Magnussen LV
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.
    Kapoor D; Clarke S; Stanworth R; Channer KS; Jones TH
    Eur J Endocrinol; 2007 May; 156(5):595-602. PubMed ID: 17468196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
    Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone therapy preserves muscle strength and power in aging men with type 2 diabetes-a randomized controlled trial.
    Magnussen LV; Hvid LG; Hermann AP; Hougaard DM; Gram B; Caserotti P; Andersen MS
    Andrology; 2017 Sep; 5(5):946-953. PubMed ID: 28914503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body oxidative stress reduction during testosterone therapy in aging men: A randomized placebo-controlled trial.
    Christensen LL; Poulsen HE; Andersen MS; Glintborg D
    Andrology; 2024 Jan; 12(1):115-122. PubMed ID: 37177884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of strength training and testosterone treatment on soluble CD36 in aging men: Possible relation to changes in body composition.
    Glintborg D; Christensen LL; Kvorning T; Larsen R; Højlund K; Brixen K; Hougaard DM; Handberg A; Andersen M
    Scand J Clin Lab Invest; 2015; 75(8):659-66. PubMed ID: 26264425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
    Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.
    Page ST; Amory JK; Bowman FD; Anawalt BD; Matsumoto AM; Bremner WJ; Tenover JL
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1502-10. PubMed ID: 15572415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of androgen therapy on adipose tissue and metabolism in older men.
    Schroeder ET; Zheng L; Ong MD; Martinez C; Flores C; Stewart Y; Azen C; Sattler FR
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4863-72. PubMed ID: 15472177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone therapy increased muscle mass and lipid oxidation in aging men.
    Frederiksen L; Højlund K; Hougaard DM; Brixen K; Andersen M
    Age (Dordr); 2012 Feb; 34(1):145-56. PubMed ID: 21347608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of age on leptin and adiponectin independent of adiposity.
    Schautz B; Later W; Heller M; Peters A; Müller MJ; Bosy-Westphal A
    Br J Nutr; 2012 Jul; 108(2):363-70. PubMed ID: 22370102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.
    Emmelot-Vonk MH; Verhaar HJ; Nakhai Pour HR; Aleman A; Lock TM; Bosch JL; Grobbee DE; van der Schouw YT
    JAMA; 2008 Jan; 299(1):39-52. PubMed ID: 18167405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.
    Herbst KL; Anawalt BD; Amory JK; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1167-73. PubMed ID: 12629101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study.
    Bouloux PM; Legros JJ; Elbers JM; Geurts TB; Kaspers MJ; Meehan AG; Meuleman EJ;
    Aging Male; 2013 Jun; 16(2):38-47. PubMed ID: 23581697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.